EP2849792 - Bibliographic data
FORMULATION LIQUIDE
Last update | 07/06/2025 |
---|---|
Legal status | Brevet déchu |
Origin | Euro-PCT |
(73) Holder |
LUODA PHARMA LIMITED Lvl 2, 134/135 Baggot Street Lower
Dublin 2
Irlande
|
---|---|
(72) Inventors |
Nicholas BOVA Suite 1
304-318 The Kingsway
Caringbah New South Wales 2229
Australie
Stephen PAGE 55 Campbell Street
Newtown New South Wales 2042
Australie
Giuseppe PIPPIA PO Box 2079
Boronia Park, New South Wales 2111
Australie
|
(74) Agent |
Mail recipient
AWA SWEDEN AB P.O. Box 5117
200 71 Malmö
Suède
|
(21) Request number | EP13791455.2 |
---|---|
(22) Request date | 17/05/2013 |
(11) Publication number | EP2849792 |
---|---|
Publication date | 04/03/2020 |
(54) Title of the invention | FORMULATION LIQUIDE |
---|---|
(51) International classification | A61K 47/10, A61K 31/4184, A61K 31/401, A61K 9/08, A61P 9/10 |
International classification (before reform) | None |
Claimed priority |
(31) Number: 2012902062 |
---|---|
Initial application | None |
Divisional application | EP20160396.6 /EP3682902 None |
Expected annuity |
Annuity: 8 -
Amount: 140 € -
Due date 02/06/2020
Surtax: 8 - Amount: 28 € - Due date 03/12/2020 |
---|---|
Last annuity | None |
Publication | None |
---|---|
History | Publication de la délivrance du brevet européen - Legal date 04/03/2020 Entrée en période de grâce du brevet d'invention - Legal date 03/06/2020 Déchéance du brevet d'invention après période de grâce - Legal date 02/06/2020 |